wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37301465-0E03FBD8-F446-4957-872B-C4909867E034
Q37301465-0E03FBD8-F446-4957-872B-C4909867E034
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37301465-0E03FBD8-F446-4957-872B-C4909867E034
Optimizing tyrosine kinase inhibitor therapy in gastrointestinal stromal tumors: exploring the benefits of continuous kinase suppression.
P2860
Q37301465-0E03FBD8-F446-4957-872B-C4909867E034
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37301465-0E03FBD8-F446-4957-872B-C4909867E034
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
068b94bb18ebb40621208b3bb1326db6bbcec6e9
P2860
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.